These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7614847)

  • 21. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.
    Huang XR; Chen WY; Truong LD; Lan HY
    J Am Soc Nephrol; 2003 Jul; 14(7):1738-47. PubMed ID: 12819233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.
    Eriguchi M; Lin M; Yamashita M; Zhao TV; Khan Z; Bernstein EA; Gurley SB; Gonzalez-Villalobos RA; Bernstein KE; Giani JF
    Am J Physiol Renal Physiol; 2018 Apr; 314(4):F531-F542. PubMed ID: 29187372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ultrastructure of the kidney in spontaneously diabetic KK mice].
    du Boistesselin R; Racadot O; Duhault J; Racadot J
    C R Seances Soc Biol Fil; 1973; 167(12):1722-4. PubMed ID: 4371505
    [No Abstract]   [Full Text] [Related]  

  • 25. Basal lamina layering in diabetes mellitus. Evidence for accelerated rate of cell death and cell regeneration.
    Vracko R
    Diabetes; 1974 Feb; 23(2):94-104. PubMed ID: 4590447
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tubulointerstitial injury in diabetes mellitus (including Armanni-Ebstein lesion)].
    Watanabe Y; Hotta N
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):225-8. PubMed ID: 9277902
    [No Abstract]   [Full Text] [Related]  

  • 27. Etiologic variability of nephropathy in juvenile diabetes mellitus.
    Gilboa N; Durante D; McIntosh RM; Guggenheim S
    Arch Pathol Lab Med; 1979 Aug; 103(9):479-82. PubMed ID: 582380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy.
    Ina K; Kitamura H; Tatsukawa S; Takayama T; Fujikura Y; Shimada T
    Med Electron Microsc; 2002 Jun; 35(2):87-95. PubMed ID: 12181650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
    Gilbert RE; Cox A; Wu LL; Allen TJ; Hulthen UL; Jerums G; Cooper ME
    Diabetes; 1998 Mar; 47(3):414-22. PubMed ID: 9519748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Urinary alanine aminopeptidase in diabetic patients].
    Sato T; Hosoi M; Fujii S
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():568-74. PubMed ID: 12355810
    [No Abstract]   [Full Text] [Related]  

  • 31. The Renal Tubulointerstitium.
    Nast CC
    Adv Chronic Kidney Dis; 2017 Mar; 24(2):55-56. PubMed ID: 28284379
    [No Abstract]   [Full Text] [Related]  

  • 32. Myofibroblast involvement in tubular basement membrane remodeling in type II diabetic nephropathy.
    Mandache E; Gherghiceanu M; Serafinceanu C; Penescu M; Mircescu G
    Rom J Morphol Embryol; 2011; 52(1):75-9. PubMed ID: 21424035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of tubular epithelial cells in diabetic nephropathy.
    Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
    Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Armanni-Ebstein lesion in a diabetic patient with acute tubular injury.
    Jagannathan G; Finkielstein VA; Markowitz GS; Kudose S
    Kidney Int; 2022 Jul; 102(1):213. PubMed ID: 35738835
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic implications of renal hypertrophy in diabetes mellitus.
    Kleinman KS; Fine LG
    Diabetes Metab Rev; 1988 Mar; 4(2):179-89. PubMed ID: 3281809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Navigating pathways affecting type 1 diabetic kidney disease.
    Pasquali L; Trucco M; Ringquist S
    Pediatr Diabetes; 2007 Oct; 8(5):307-22. PubMed ID: 17850474
    [No Abstract]   [Full Text] [Related]  

  • 37. Significance of tubulointerstitial changes in diabetic renal disease.
    Ziyadeh FN
    Kidney Int Suppl; 1996 May; 54():S10-3. PubMed ID: 8731186
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy.
    Singh DK; Winocour P; Farrington K
    Nat Clin Pract Nephrol; 2008 Apr; 4(4):216-26. PubMed ID: 18268525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.
    Dixon A; Maric C
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1678-90. PubMed ID: 17686959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tubuloglomerular feedback in renal hypertrophy.
    Pollock CA; Lawrence JR; Field MJ
    Kidney Int Suppl; 1991 Jun; 32():S106-9. PubMed ID: 1881031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.